Onconova Therapeutics, Inc.
USD35.44
+5.20 (+17.19%)
CEO
Steven M. Fruchtman
IPO Date
2013-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.58
Prev. Close
$30.24
Day Low
$31.58
Day High
$43.14
52W Low
$24.00
52W High
$43.14
Market Cap
$0.74B
Volume
0.11M
| -0.3 |
| 31 Dec 2023 | FY | 100.0% | -8384.1% | -177.5% | -83.5% | 0.00 | 2.46 | -0.8 |
| 31 Dec 2022 | FY | 100.0% | -8391.2% | -67.0% | -48.2% | 0.00 | 4.89 | -0.7 |
| 31 Dec 2021 | FY | 100.0% | -7151.8% | -35.0% | -29.1% | 0.00 | 9.06 | -2.7 |
| 31 Dec 2020 | FY | 100.0% | -10890.5% | -407.4% | -125.9% | 0.00 | 1.97 | -3.3 |
| 31 Dec 2019 | FY | 100.0% | -985.0% | -185.8% | -90.8% | 0.00 | 2.83 | -0.3 |
| 31 Dec 2018 | FY | 0.0% | -1675.3% | -381.9% | -114.8% | 0.00 | 2.11 | -0.4 |
| 31 Dec 2017 | FY | 0.0% | -3061.2% | 206.1% | -483.9% | 0.00 | 0.49 | -0.6 |
| 31 Dec 2016 | FY | 0.0% | -354.6% | -457.7% | -84.7% | 0.00 | 2.27 | -0.5 |
| -0.3 |
| 30 Jun 2025 | Q2 | 100.0% | -33.5% | -11.1% | -5.9% | 0.00 | 2.09 | -2.4 |
| 31 Dec 2024 | Q4 | 96.5% | -14868.4% | 26.8% | -34.0% | 0.00 | 2.16 | -0.3 |
| 30 Jun 2024 | Q2 | 100.0% | -8898.2% | 4.7% | -26.7% | 0.00 | 1.88 | -0.5 |
| 31 Dec 2023 | Q4 | 96.5% | -7896.5% | -83.6% | -39.3% | 0.00 | 2.46 | -0.4 |
| 30 Jun 2023 | Q2 | 100.0% | -8871.7% | -53.0% | -32.9% | 0.00 | 3.51 | -0.6 |
| 31 Dec 2022 | Q4 | 96.5% | -9573.5% | -38.2% | -27.5% | 0.00 | 4.89 | -0.3 |
| 30 Jun 2022 | Q2 | 100.0% | -7208.8% | -21.2% | -16.9% | 0.00 | 7.44 | -0.8 |
| 31 Dec 2021 | Q4 | 96.5% | -6386.7% | -15.6% | -13.0% | 0.00 | 9.06 | -1.8 |